What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1455759

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1455759

France and Germany Probiotic Food Supplements Market - 2023-2030

PAGES: 210 Pages
DELIVERY TIME: 2 business days
PDF & Excel (Single User License)
USD 3750
PDF & Excel (Multiple User License)
USD 4000
PDF & Excel (Enterprise License)
USD 7250

Add to Cart


France and Germany Probiotic Food Supplements Market reached US$ 334.76 million in 2022 and is expected to reach US$ 614.65 million by 2030, growing with a CAGR of 8.05% during the forecast period 2023-2030.

Probiotic food supplements are dietary supplements containing live microorganisms, typically bacteria or yeast, that confer health benefits when consumed in adequate amounts. These microorganisms are similar to beneficial bacteria naturally found in the human gut microbiota. Probiotic supplements are formulated to enhance the balance of beneficial bacteria in the gastrointestinal tract, promoting digestive health and potentially offering other health benefits.

Growing awareness of the link between gut health and overall well-being is driving increased interest in probiotic food supplements among consumers in France and Germany. Consumers in Germany are increasingly seeking natural and organic probiotic food supplements made with clean-label ingredients and minimal additives.

The probiotic food supplements market in Germany is witnessing a proliferation of product offerings, including capsules, tablets, powders, liquids, and gummies, catering to diverse consumer preferences and lifestyle needs. There is a growing demand for probiotic food supplements formulated to address specific health concerns, such as digestive disorders, immune support, women's health, and stress management.

The digestive application segment and tablet form account for the largest share of the France and German probiotic food supplements market. There is a growing demand for probiotic food supplements formulated to address specific health concerns, such as digestive disorders, immune support, women's health, and stress management.


Rising Prevalence of Digestive Disorders

The rising prevalence of digestive disorders is poised to drive significant growth in the probiotic food supplements market in both France and Germany. Probiotics are gaining widespread recognition for their potential to improve gut health and alleviate digestive issues.

As consumers become more health-conscious and seek natural remedies for gastrointestinal problems, the demand for probiotic food supplements is expected to surge in both countries.

In the French market, the increasing awareness of gut health and overall well-being is propelling the demand for probiotic food supplements. With a growing emphasis on preventive healthcare, consumers are proactively seeking products that can support digestive health. This trend is further fueled by the availability of a wide range of probiotic food supplements in various forms such as capsules, tablets, and powders, catering to diverse consumer preferences.

The strong tradition of dietary supplements in Germany, coupled with the country's advanced healthcare infrastructure, contributes to the favorable market conditions for probiotic products.

According to data from the DigestScience Foundation, France experiencing a notably high incidence of Crohn's disease compared to its European counterparts. Each year, nearly 4,000 new cases of Crohn's disease are diagnosed in the country. Typically, the onset of this condition occurs during early adulthood, with a peak between the ages of 25 and 30. Surprisingly, more than 10% of patients receive their diagnosis before reaching the age of 17.

Rising Preference for Natural Remedies

Consumers in France and Germany are embracing holistic health approaches that focus on treating the root cause of health issues rather than alleviating symptoms. Probiotic food supplements are perceived as holistic remedies that promote overall health by balancing the gut microbiota, supporting immune function, and enhancing nutrient absorption.

Increasing consumer awareness regarding the potential health benefits of natural remedies, including probiotic food supplements. Consumers in France and Germany are becoming more aware of the role of gut health in overall well-being and are actively seeking natural solutions to support immune function. Both France and Germany have strong traditions of using natural remedies and alternative medicine to maintain health and treat illnesses. Probiotic food supplements, which are derived from beneficial bacteria found in fermented foods, align with this cultural preference for natural and traditional healing modalities.

There's a growing trend toward reducing reliance on synthetic medications and pharmaceutical drugs, driven by concerns about potential side effects and long-term health implications. Probiotic food supplements offer a natural alternative to pharmaceuticals for managing digestive issues, immune system support, and overall wellness, appealing to consumers seeking gentler, safer treatment options.

Functional foods, which offer health benefits beyond basic nutrition, are gaining popularity among health-conscious consumers in France and Germany. Probiotic food supplements are considered functional foods due to their ability to confer health benefits beyond basic nutrition, such as promoting digestive health and immune system support. The demand for functional foods is expected to drive growth in the probiotic supplements market.

Stringent Regulatory Framework

The stringent regulations governing probiotic food supplements in France and Germany require manufacturers to adhere to strict standards for product safety, quality, and efficacy. Meeting these regulatory requirements can pose significant challenges for market players, particularly smaller manufacturers with limited resources for compliance activities.

Obtaining regulatory approval for probiotic food supplements in France and Germany involves navigating a complex and time-consuming approval process. Manufacturers must submit comprehensive documentation, including scientific evidence supporting the safety and efficacy of their products, for review by regulatory authorities. The lengthy approval process can delay product launches and hinder market entry for new players.

Regulatory authorities in France and Germany impose restrictions on the types of health claims that can be made for probiotic food supplements. Manufacturers are prohibited from making unsubstantiated or misleading claims about the health benefits of their products, requiring them to provide scientific evidence to support any health claims made in product labeling and marketing materials. These restrictions limit the ability of manufacturers to differentiate their products based on health claims, potentially hindering market growth.

The regulatory framework in France and Germany imposes strict labeling requirements for probiotic food supplements, including mandatory disclosure of ingredients, dosage instructions, and potential allergens. Manufacturers must ensure compliance with these labeling requirements to avoid regulatory penalties and maintain consumer trust. However, the complexity of labeling regulations can create additional compliance burdens for market players.

Segment Analysis

The France and Germany probiotic food supplements market is segmented based on strain, form, distribution channel, application, and end-user

Increasing Demand for probiotic food supplements is indeed associated with digestive health benefits

The digestive health segment accounts for the largest share of the France and Germany probiotic food supplements Market. In the France probiotic food supplements market, the application segment of digestive health holds a significant share, reflecting the growing awareness and emphasis on gut health among consumers. Probiotic supplements, containing beneficial bacteria strains such as Lactobacillus and Bifidobacterium, are specifically formulated to support digestive function and promote a healthy gut microbiome.

One key driver behind the prominence of digestive health in the France probiotic food supplements market is the rising prevalence of digestive disorders and gastrointestinal discomfort. According to a White Book of Gastroenterology and Hepatology in France, by CNP-HGE, National Professional Council of Hepato-Gastroenterology, every year, more than 5 million individuals in France are treated by doctors for digestive disease or symptoms.

Factors such as stress, poor dietary habits, and lifestyle choices have contributed to an increase in digestive issues among the population, driving the demand for effective solutions like probiotics. Consumers are seeking natural and convenient ways to alleviate digestive discomfort and improve overall gut health, leading to a surge in the consumption of probiotic food supplements targeting digestive wellness. As consumers increasingly prioritize digestive wellness, probiotic supplements have emerged as a popular choice for addressing digestive issues such as bloating, indigestion, and irregular bowel movements.

Competitive Landscape

The major global players in the market include EXDEN, TargEDys, SYMBIOPHARM GMBH, HLH BioPharma GmbH, MILEI GmbH, Danone, GLORYFEEL GMBH, GAL VITAMIN DEUTSCHLAND GMBH, ROQUETTE FRERES, Nutergia Laboratory

COVID-19 Impact Analysis

The COVID-19 pandemic impacted the probiotic food supplements market, with the increased focus on health and immunity leading to increased demand for immune-supporting products. However, challenges like supply chain disruptions, lockdown measures, and economic factors impacted accessibility and demand. The market's growth is expected in the post-pandemic period, driven by growing awareness of health and wellness benefits and supply chain recovery.

By Strain

  • Lactobacillus
  • Streptococcus
  • Bifidobacterium
  • Others

By Form

  • Tablet
  • Capsules
  • Liquid
  • Powder
  • Gummies
  • Others

By Distribution Channel

  • Supermarket/ Hypermarket
  • Pharmacy/health Stores
  • Online Channel
  • Others

By Application

  • Digestive Health
  • Immune Health
  • Skin Health
  • Mental Health
  • Others

By End-User

  • Children
  • Adults
  • Seniors

Key Developments

  • In February 2024, ProBiotix Health plc announced a partnership agreement with SymbioPharm, a German company pioneering in microbiome research and knowledge-based probiotics. The agreement allows SymbioPharm to utilize ProBiotix's CholBiome CH formulation to target and reduce cholesterol in its branded consumer products. SymbioPharm has introduced the CholBiome CH formulation as a premium pharmacy supplement solution across targeted regions. The agreement covers sales in Germany, Austria, and Switzerland, focusing on maximizing market penetration through strategic pharmacy partnerships.
  • In May 2023, French family company Biocodex acquired 100% of TargEDys shares, to consolidate the group's strong ambition in the Microbiome and accelerate TargEDys development globally.
  • In November 2022, TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife Satylia in Germany. The novel dietary supplement is based on the next-generation probiotic Hafnia alvei HA4597.

Why Purchase the Report?

  • To visualize the France and Germany probiotic food supplements market segmentation based on strain, form, distribution channel, application, and end-user, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of probiotic food supplement market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The France and Germany Probiotic Food Supplements Market report would provide approximately 45 tables, 43 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: FB8219

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Strain
  • 3.2.Snippet by Form
  • 3.3.Snippet by Distribution Channel
  • 3.4.Snippet by Application
  • 3.5.Snippet by End User


  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • Prevalence of Digestive Disorders
      • Preference for Natural Remedies
    • 4.1.2.Restraints
      • Regulatory Framework
      • Product Cost
    • 4.1.3.Opportunity
      • Retail Channels
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Strain

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
    • 7.1.2.Market Attractiveness Index, By Strain
  • 7.2.Lactobacillus*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Streptococcus
  • 7.4.Bifidobacterium
  • 7.5.Others

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Tablet*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Capsules
  • 8.4.Liquid
  • 8.5.Powder
  • 8.6.Gummies
  • 8.7.Others

9.By Distribution Channel

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2.Market Attractiveness Index, By Distribution Channel
  • 9.2.Supermarket/ Hypermarket*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Pharmacy/health Stores
  • 9.4.Online Channel
  • 9.5.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Digestive Health*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Immune Health
  • 10.4.Skin Health
  • 10.5.Mental Health
  • 10.6.Others

11.By End User

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2.Market Attractiveness Index, By End User
  • 11.2.Children*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Adults
  • 11.4.Seniors

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.EXDEN*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.TargEDys
  • 13.4.HLH BioPharma GmbH
  • 13.5.MILEI GmbH
  • 13.6.Danone
  • 13.10.Nutergia Laboratory



  • 14.1.About Us and Services
  • 14.2.Contact Us
Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!